<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39036098</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Long COVID: cognitive, balance, and retina manifestations.</ArticleTitle><Pagination><StartPage>1399145</StartPage><MedlinePgn>1399145</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1399145</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1399145</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The neurological symptoms of Long COVID (LC) and the impact of neuropsychological manifestations on people's daily lives have been extensively described. Although a large body of literature describes symptoms, validating this with objective measures is important. This study aims to identify and describe the effects of Long COVID on cognition, balance, and the retinal fundus, and determine whether the duration of symptoms influences cognitive impairment.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This cross-sectional study involved LC volunteers with cognitive complaint from public health centers in northern Barcelona who participated between January 2022 and March 2023. This study collected sociodemographic characteristics, information on substance use, comorbidities, and clinical data related to COVID-19. We measured five cognitive domains using a battery of neuropsychological tests. Balance was assessed through posturography and retinal vascular involvement by retinography.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 166 people with LC and cognitive complaints participated, 80.72% were women and mean age was 49.28&#x2009;&#xb1;&#x2009;8.39&#x2009;years. The most common self-reported symptoms were concentration and memory deficit (98.80%), brain fog (82.53%) and insomnia (71.17%). The 68.67% presented cognitive deficit in at least one domain, with executive functions being the most frequent (43.98%). The 51.52% of the participants exhibited a dysfunctional pattern in balance, and 9.2% showed some alteration in the retina. There were no statistically significant differences between cognitive impairment and symptom duration.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our findings contribute to a more comprehensive understanding of the pathology associated with Long COVID. They highlight the diversity of self-reported symptoms, the presence of abnormal balance patterns, and some cognitive impairment. These findings underscore the necessity of addressing the clinical management of this condition in primary care through follow-up and the pursuit of multidisciplinary and comprehensive treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Carmona-Cervell&#xf3;, Le&#xf3;n-G&#xf3;mez, Dacosta-Aguayo, Lamonja-Vicente, Montero-Al&#xed;a, Molist, Ayet, Chac&#xf3;n, Costa-Garrido, L&#xf3;pez-Lifante, Zamora-Putin, Liutsko, Garc&#xed;a-Sierra, Forn&#xe9;s, Moreno-Gabriel, Massanella, Mu&#xf1;oz-Moreno, Rodr&#xed;guez-P&#xe9;rez, Mateu, Prats, Matar&#xf3;, Boigues, Quirant, Prado, Mart&#xed;nez-C&#xe1;ceres, Viol&#xe1;n, Tor&#xe1;n-Monserrat and the APC Collaborative Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Carmona-Cervell&#xf3;</LastName><ForeName>Meritxell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Le&#xf3;n-G&#xf3;mez</LastName><ForeName>Brenda Biaani</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dacosta-Aguayo</LastName><ForeName>Rosalia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamonja-Vicente</LastName><ForeName>Noem&#xed;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de Recerca en Impacte de les Malalties Cr&#xf2;niques i les Seves Traject&#xf2;ries (GRIMTra), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montero-Al&#xed;a</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Research Group in Health and Society (GREMSAS), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molist</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Vic-Central University of Vic, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayet</LastName><ForeName>Aitana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chac&#xf3;n</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de Recerca en Impacte de les Malalties Cr&#xf2;niques i les Seves Traject&#xf2;ries (GRIMTra), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa-Garrido</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Lifante</LastName><ForeName>Victor M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Research Group in Health and Society (GREMSAS), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palau-Solit&#xe0; Healthcare Centre, Institut Catal&#xe0; de la Salut, Palau-Solit&#xe0; Plegamans, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamora-Putin</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palau-Solit&#xe0; Healthcare Centre, Institut Catal&#xe0; de la Salut, Palau-Solit&#xe0; Plegamans, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liutsko</LastName><ForeName>Liudmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Sierra</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Research Group in Health and Society (GREMSAS), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nursing Department, Faculty of Medicine, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forn&#xe9;s</LastName><ForeName>Ant&#xf2;nia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Gabriel</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Research Group in Health and Society (GREMSAS), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social Psychology, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massanella</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IrsiCaixa-AIDS Research Institute, Can Ruti Campus, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Red Espa&#xf1;ola de investigaci&#xf3;n en Covid Persisitente, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Moreno</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Fundaci&#xf3; Lluita Contra les Infeccions, Germans Trias i Pujol Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Psychology and Education Sciences, Universitat Oberta de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-P&#xe9;rez</LastName><ForeName>M Carmen</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Research Group in Health and Society (GREMSAS), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mateu</LastName><ForeName>Lourdes</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Red Espa&#xf1;ola de investigaci&#xf3;n en Covid Persisitente, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Department, Fundaci&#xf3; Lluita Contra les Infeccions, Germans Trias i Pujol Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Fundaci&#xf3; Lluita Contra les Infeccions, Germans Trias i Pujol Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matar&#xf3;</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Psychology and Psychobiology, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Neuroci&#xe8;ncies, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Recerca Sant Joan de D&#xe9;u, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boigues</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immunology Department, FOCIS Center of Excellence, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Division, Laboratori Cl&#xed;nic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular Biology, Physiology and Immunology,Universitat Aut&#xf2;noma de Barcelona, Bellaterra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quirant</LastName><ForeName>Bibiana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Immunology Department, FOCIS Center of Excellence, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Division, Laboratori Cl&#xed;nic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular Biology, Physiology and Immunology,Universitat Aut&#xf2;noma de Barcelona, Bellaterra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prado</LastName><ForeName>Julia G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IrsiCaixa-AIDS Research Institute, Can Ruti Campus, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-C&#xe1;ceres</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Department, FOCIS Center of Excellence, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Division, Laboratori Cl&#xed;nic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viol&#xe1;n</LastName><ForeName>Concepci&#xf3;n</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de Recerca en Impacte de les Malalties Cr&#xf2;niques i les Seves Traject&#xf2;ries (GRIMTra), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Red de Investigaci&#xf3;n en Cronicidad, Atenci&#xf3;n Primaria y Prevenci&#xf3;n y Promoci&#xf3;n de la Salud, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tor&#xe1;n-Monserrat</LastName><ForeName>Pere</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Research Group in Health and Society (GREMSAS), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine,Universitat de Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>APC Collaborative Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neurological symptoms</Keyword><Keyword MajorTopicYN="N">neuropsychological assessment</Keyword><Keyword MajorTopicYN="N">postural balance</Keyword><Keyword MajorTopicYN="N">retina fundus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>22</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39036098</ArticleId><ArticleId IdType="pmc">PMC11260168</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1399145</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative . Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. (2022) 400:452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Safarpour A, Lunz Trujillo K, Simonson MD, et al. . Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open. (2022) 5:E2238804. doi: 10.1001/jamanetworkopen.2022.38804, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med. (2023) 29:2347&#x2013;57. doi: 10.1038/s41591-023-02521-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . A clinical case definition of post COVID-19 condition by a Delphi consensus. (2021). Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (Accessed October 26, 2022).</Citation></Reference><Reference><Citation>FAIR Health . Patients diagnosed with post-COVID conditions. An analysis of private healthcare claims using the official ICD-10 diagnostic code. Radiological Society of North America Inc. Diagnosed with Post-COVID Conditions - A FAIR Health White Paper. (2022). Available at: https://s3.amazonaws.com/media2.fairhealth.org/whitepaper/asset/Patients (Accessed June 10, 2023).</Citation></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. . Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. (2021) 8:1&#x2013;8. doi: 10.3389/fcvm.2021.745758, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyatos P, Luque N, Sabater G, Eizaguirre S, Bonnin M, Orriols R, et al. . Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection. Infection. (2024). doi: 10.1007/s15010-024-02173-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-024-02173-5</ArticleId><ArticleId IdType="pmc">PMC11289012</ArticleId><ArticleId IdType="pubmed">38324145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T, Kuroda N, Sone D. Neuropsychiatric aspects of long COVID: a comprehensive review. Psychiatry Clin Neurosci. (2023) 77:84&#x2013;93. doi: 10.1111/pcn.13508, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13508</ArticleId><ArticleId IdType="pmc">PMC10108156</ArticleId><ArticleId IdType="pubmed">36385449</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. (2022) 434:120162. doi: 10.1016/j.jns.2022.120162, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. doi: 10.1038/s41591-022-01909-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Demko ZO, Yu T, Mullapudi SK, Varela Heslin MG, Dorsey CA, Payton CB, et al. . Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection. medRxiv. (2022) 2022:22278543. doi: 10.1101/2022.08.08.22278543, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.08.22278543</ArticleId><ArticleId IdType="pmc">PMC9387157</ArticleId><ArticleId IdType="pubmed">35982674</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and Meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. (2022) 11:269. doi: 10.3390/pathogens11020269, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, Bahmer T, Chaplinskaya-Sobol I, Deckert J, Endres M, Franzp&#xf6;tter K, et al. . Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. eClinicalMedicine. (2024) 69:102456. doi: 10.1016/j.eclinm.2024.102456, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2024.102456</ArticleId><ArticleId IdType="pmc">PMC10847699</ArticleId><ArticleId IdType="pubmed">38333368</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. (2021) 38:101019. doi: 10.1016/J.ECLINM.2021.101019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ECLINM.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatys-Bogacka Z, Mazurkiewicz I, Slowik J, Bociaga-Jasik M, Dzieza-Grudnik A, Slowik A, et al. . Brain fog and quality of life at work in non-hospitalized patients after COVID-19. Int J Environ Res Public Health. (2022) 19:12816. doi: 10.3390/ijerph191912816, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912816</ArticleId><ArticleId IdType="pmc">PMC9564568</ArticleId><ArticleId IdType="pubmed">36232113</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, et al. . Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS One. (2021) 16:e0254523&#x2013;19. doi: 10.1371/journal.pone.0254523, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. (2022) 101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera E, P&#xe9;rez-S&#xe1;nchez MC, San Miguel-Abella R, Barrenechea A, Blanco C, Solares L, et al. . Cognitive impairment in young adults with post COVID-19 syndrome. Sci Rep. (2023) 13:1&#x2013;9:6378. doi: 10.1038/s41598-023-32939-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32939-0</ArticleId><ArticleId IdType="pmc">PMC10113715</ArticleId><ArticleId IdType="pubmed">37076533</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Pedersen JK, Gunnarsson DV, Roikjer TK, Podlekareva D, Hansen H, et al. . Cognitive impairments among patients in a long-COVID clinic: prevalence, pattern and relation to illness severity, work function and quality of life. J Affect Disord. (2023) 324:162&#x2013;9. doi: 10.1016/j.jad.2022.12.122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.12.122</ArticleId><ArticleId IdType="pmc">PMC9795797</ArticleId><ArticleId IdType="pubmed">36586593</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. (2022) 604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M, Yus M, G&#xf3;mez-Ruiz N, Polidura C, Gil-Mart&#xed;nez L, Delgado-Alonso C, et al. . Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain. (2022) 146:2142&#x2013;52. doi: 10.1093/brain/awac384, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac384</ArticleId><ArticleId IdType="pmc">PMC9620345</ArticleId><ArticleId IdType="pubmed">36288544</ArticleId></ArticleIdList></Reference><Reference><Citation>Degen CV, Mikuteit M, Niewolik J, Schr&#xf6;der D, Vahldiek K, M&#xfc;cke U, et al. . Self-reported tinnitus and Vertigo or dizziness in a cohort of adult long COVID patients. Front Neurol. (2022) 13:1&#x2013;6. doi: 10.3389/fneur.2022.884002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.884002</ArticleId><ArticleId IdType="pmc">PMC9082801</ArticleId><ArticleId IdType="pubmed">35547372</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola P, Ralli M, Pisani D, Malanga D, Sculco D, Messina L, et al. . Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol. (2021) 278:3725&#x2013;30. doi: 10.1007/s00405-020-06440-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06440-7</ArticleId><ArticleId IdType="pmc">PMC7582442</ArticleId><ArticleId IdType="pubmed">33095432</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;z&#xe7;elik Korkmaz M, E&#x11f;ilmez OK, &#xd6;z&#xe7;elik MA, G&#xfc;ven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol. (2021) 278:1675&#x2013;85. doi: 10.1007/s00405-020-06396-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06396-8</ArticleId><ArticleId IdType="pmc">PMC7532931</ArticleId><ArticleId IdType="pubmed">33011957</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzi&#x119;cio&#x142;-Anikiej Z, Dakowicz A, Dzi&#x119;cio&#x142; J, Kopko S, Moskal-Jasi&#x144;ska D, Gawlikowska-Sroka A, et al. . Balance disorders in people with history of COVID-19 in light of Posturographic tests. J Clin Med. (2023) 12:461. doi: 10.3390/jcm12134461, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12134461</ArticleId><ArticleId IdType="pmc">PMC10342615</ArticleId><ArticleId IdType="pubmed">37445496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F, M&#xe9;ar L, Edvinsson &#xc5;, Micke P, Uhl&#xe9;n M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol. (2020) 16:e9610&#x2013;6. doi: 10.15252/msb.20209610, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Dacosta-Aguayo R, Lamonja-Vicente N, Chacon C, Carrasco-Ribelles LA, Montero-Alia P, Costa-Garrido A, et al. . Neurocognitive profile of the post-COVID condition in adults in Catalonia-a mixed method prospective cohort and nested case-control study: study protocol. Vaccine. (2022) 10:849. doi: 10.3390/vaccines10060849, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10060849</ArticleId><ArticleId IdType="pmc">PMC9230542</ArticleId><ArticleId IdType="pubmed">35746457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministerio de Sanidad . L&#xed;mites de consumo de bajo riesgo de alcohol. Actualizaci&#xf3;n del riesgo relacionado con los niveles de consumo de alcohol, el patr&#xf3;n de consumo y el tipo de bebida. (2020). Available at: https://www.sanidad.gob.es/areas/promocionPrevencion/alcohol/documentosTecnicos/docs/Limites_Consumo_Bajo_Riesgo_Alcohol_Actualizacion.pdf.</Citation></Reference><Reference><Citation>World Health Organization . A healthy lifestyle - WHO recommendations. (2010). Available at: https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations (Accessed June 24, 2023).</Citation></Reference><Reference><Citation>Cysique LA, &#x141;ojek E, Cheung TCK, Cullen B, Egbert AR, Evans J, et al. . Assessment of neurocognitive functions, olfaction, taste, mental, and psychosocial Health in COVID-19 in adults: recommendations for harmonization of research and implications for clinical practice. J Int Neuropsychol Soc. (2022) 28:642&#x2013;60. doi: 10.1017/S1355617721000862, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617721000862</ArticleId><ArticleId IdType="pmc">PMC8825876</ArticleId><ArticleId IdType="pubmed">34365990</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Casanova J, Qui&#xf1;ones-&#xda;beda S, Gramunt-Fombuena N, Quintana-Aparicio M, Aguilar M, Badenes D, et al. . Spanish multicenter normative studies (NEURONORMA project): norms for verbal fluency tests. Arch Clin Neuropsychol. (2009) 24:395&#x2013;411. doi: 10.1093/arclin/acp042, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acp042</ArticleId><ArticleId IdType="pubmed">19648583</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo F, Casals-Coll M, S&#xe1;nchez-Benavides G, Quintana M, Manero RM, Rognoni T, et al. . Estudios normativos espa&#xf1;oles en poblaci&#xf3;n adulta joven (Proyecto NEURONORMA j&#xf3;venes): Normas para las pruebas span verbal, span visuoespacial, Letter-Number Sequencing, Trail Making Test y Symbol Digit Modalities Test. Neurologia. (2012) 27:319&#x2013;29. doi: 10.1016/j.nrl.2011.12.020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2011.12.020</ArticleId><ArticleId IdType="pubmed">22405214</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler D. WAIS-iii Escala de Inteligencia de Wechsler para Adultos. Madrid: TEA Ediciones; (2001).</Citation></Reference><Reference><Citation>Casals-Coll M, S&#xe1;nchez-Benavides G, Quintana M, Manero RM, Rognoni T, Calvo L, et al. . Estudios normativos espa&#xf1;oles en poblaci&#xf3;n adulta joven (proyecto NEURONORMA j&#xf3;venes): Normas para los test de fluencia verbal. Neurologia. (2013) 28:33&#x2013;40. doi: 10.1016/j.nrl.2012.02.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2012.02.010</ArticleId><ArticleId IdType="pubmed">22652141</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden CJ. STROOP. Test de Colores y Palabras. 3 Edici&#xf3;n. Madrid: TEA Ediciones; (2001).</Citation></Reference><Reference><Citation>Schmidt M. Rey auditory and verbal learning test: A handbook. Los Angeles, CA: Western Psychological Services; (1996).</Citation></Reference><Reference><Citation>Palomo R, Casals-Coll M, S&#xe1;nchez-Benavides G, Quintana M, Manero RM, Rognoni T, et al. . Estudios normativos espa&#xf1;oles en poblaci&#xf3;n adulta joven (proyecto NEURONORMA j&#xf3;venes): Normas para las pruebas Rey-Osterrieth Complex Figure (copia y memoria) y Free and Cued Selective Reminding Test. Neurologia. (2013) 28:226&#x2013;35. doi: 10.1016/j.nrl.2012.03.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2012.03.008</ArticleId><ArticleId IdType="pubmed">22652140</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodglass H, Kaplan E, Barresi B. Test de Boston para el Diagn&#xf3;stico de la Afasia. 3rd ed. Madrid: Editorial M&#xe9;dica Panamericana; (2001).</Citation></Reference><Reference><Citation>Gates TM, Cysique LA. The chronicity of HIV infection should drive the research strategy of NeuroHIV treatment studies: a critical review. CNS Drugs. (2016) 30:53&#x2013;69. doi: 10.1007/s40263-015-0302-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-015-0302-7</ArticleId><ArticleId IdType="pmc">PMC4733144</ArticleId><ArticleId IdType="pubmed">26749584</ArticleId></ArticleIdList></Reference><Reference><Citation>Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. . Updated research nosology for HIV-associated neurocognitive disorders. Neurology. (2007) 69:1789&#x2013;99. doi: 10.1212/01.WNL.0000287431.88658.8b, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000287431.88658.8b</ArticleId><ArticleId IdType="pmc">PMC4472366</ArticleId><ArticleId IdType="pubmed">17914061</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. . Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. (2021) 27:258&#x2013;63. doi: 10.1016/j.cmi.2020.09.052, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester SV, Rusu R, Chan B, Bellows M, O&#x2019;Keefe C, Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin. (2022) 38:1391&#x2013;9. doi: 10.1080/03007995.2022.2081454, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2081454</ArticleId><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al. . Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and Meta-analysis. J Clin Med. (2022) 11:314. doi: 10.3390/jcm11247314, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. . Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. J Clin Med. (2022) 11:413. doi: 10.3390/jcm11020413, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrell G, Puente D, Jacques-Avi&#xf1;&#xf3; C, Carrasco-Ribelles LA, Viol&#xe1;n C, L&#xf3;pez-Jimen&#xe9;z T, et al. . Characterisation, symptom pattern and symptom clusters from a retrospective cohort of long COVID patients in primary care in Catalonia. BMC Infect Dis. (2024) 24:954. doi: 10.1186/s12879-023-08954-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08954-x</ArticleId><ArticleId IdType="pmc">PMC10789045</ArticleId><ArticleId IdType="pubmed">38225587</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivaldi G, Pfeffer PE, Talaei M, Basera TJ, Shaheen SO, Martineau AR. Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK study. eClinicalMedicine. (2023) 65:102251. doi: 10.1016/j.eclinm.2023.102251, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102251</ArticleId><ArticleId IdType="pmc">PMC10721552</ArticleId><ArticleId IdType="pubmed">38106559</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon RT, Wijaya VO, Al JA, Nunsio PN, Buana RB. Persistent neurological manifestations in long COVID-19 syndrome: a systematic review and meta-analysis. J Infect Public Health. (2022) 15:856&#x2013;69. doi: 10.1016/j.jiph.2022.06.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.06.013</ArticleId><ArticleId IdType="pmc">PMC9221935</ArticleId><ArticleId IdType="pubmed">35785594</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss AB, Greene C, Dayaramani C, Rauchman SH, Stecker MM, De Leon J, et al. . Long COVID, the brain, nerves, and cognitive function. Neurol Int. (2023) 15:821&#x2013;41. doi: 10.3390/neurolint15030052, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15030052</ArticleId><ArticleId IdType="pmc">PMC10366776</ArticleId><ArticleId IdType="pubmed">37489358</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Zhang Z, Zhang Z, Wang Z, Li H. Cognitive impairment after long COVID-19: current evidence and perspectives. Front Neurol. (2023) 14:182. doi: 10.3389/fneur.2023.1239182, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1239182</ArticleId><ArticleId IdType="pmc">PMC10423939</ArticleId><ArticleId IdType="pubmed">37583958</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior JWL, de Souza ACC, Borges JWP, Oliveira DN, Siqueira-Neto JI, Sobreira-Neto MA, et al. . COVID-19 associated cognitive impairment: a systematic review. Cortex. (2022) 152:77&#x2013;97. doi: 10.1016/j.cortex.2022.04.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.04.006</ArticleId><ArticleId IdType="pmc">PMC9014565</ArticleId><ArticleId IdType="pubmed">35537236</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-alonso C, Valles-salgado M, Alvarez AD, Yus M, G&#xf3;mez-Ruiz N, Jorquera M, et al. . Cognitive dysfunction associated with COVID-19: a comprehensive neuropsychological study. J Psychiatr Res. (2022) 150:40&#x2013;6. doi: 10.1016/j.jpsychires.2022.03.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-S&#xe1;nchez C, Calabria M, Grunden N, Pons C, Arroyo JA, G&#xf3;mez-Anson B, et al. . Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. (2022) 12:1&#x2013;11. doi: 10.1002/brb3.2508, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2508</ArticleId><ArticleId IdType="pmc">PMC8933779</ArticleId><ArticleId IdType="pubmed">35137561</ArticleId></ArticleIdList></Reference><Reference><Citation>Voruz P, Allali G, Benzakour L, Nuber-Champier A, Thomasson M, Jacot de Alc&#xe2;ntara I, et al. . Long COVID neuropsychological deficits after severe, moderate, or mild infection. Clin Transl Neurosci. (2022) 6:9. doi: 10.3390/ctn6020009</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ctn6020009</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, et al. . Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. (2022) 185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro M, Brigas HC, Temido-Ferreira M, Pousinha PA, Regen T, Santa C, et al. . Meningeal &#x3b3;&#x3b4; T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci Immunol. (2019) 4:5199. doi: 10.1126/sciimmunol.aay5199, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aay5199</ArticleId><ArticleId IdType="pmc">PMC6894940</ArticleId><ArticleId IdType="pubmed">31604844</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung AL, Vanderheiden A, Nordvig AS, Sissoko CA, Canoll P, Mariani MB, et al. . COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain. (2022) 145:4193&#x2013;201. doi: 10.1093/brain/awac270, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac270</ArticleId><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan KA, Weigel MK, Prakash P, Wijewardhane PR, Hasel P, Rufen-Blanchette U, et al. . Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature. (2021) 599:102&#x2013;7. doi: 10.1038/s41586-021-03960-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03960-y</ArticleId><ArticleId IdType="pubmed">34616039</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. (2022) 110:3484&#x2013;96. doi: 10.1016/j.neuron.2022.10.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, Leavy OC, Richardson M, Elneima O, McAuley HJC, Shikotra A, et al. . Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. (2022) 10:761&#x2013;75. doi: 10.1016/S2213-2600(22)00127-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu L, Tebe C, Loste C, Santos JR, Llad&#xf3;s G, L&#xf3;pez C, et al. . Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. Lancet Reg Health Eur. (2023) 33:100724. doi: 10.1016/j.lanepe.2023.100724, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100724</ArticleId><ArticleId IdType="pmc">PMC10636281</ArticleId><ArticleId IdType="pubmed">37954002</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;lmaz O, Mutlu B&#xd6;, Yaman H, Bayaz&#x131;t D, Demirhan H, Bayaz&#x131;t YA. Assessment of balance after recovery from Covid-19 disease. Auris Nasus Larynx. (2022) 49:291&#x2013;8. doi: 10.1016/j.anl.2021.08.011, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anl.2021.08.011</ArticleId><ArticleId IdType="pmc">PMC8405449</ArticleId><ArticleId IdType="pubmed">34503884</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervasoni F, LoMauro A, Ricci V, Salce G, Andreoli A, Visconti A, et al. . Balance and visual reliance in post-COVID syndrome patients assessed with a robotic system: a multi-sensory integration deficit. Neurol Sci. (2022) 43:85&#x2013;8. doi: 10.1007/s10072-021-05647-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05647-8</ArticleId><ArticleId IdType="pmc">PMC8493357</ArticleId><ArticleId IdType="pubmed">34613505</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavvas DG, Sarraf D, Sadda SVR, Eliott D, Ehlers JP, Waheed NK, et al. . Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent lancet publication. Eye. (2020) 34:2153&#x2013;4. doi: 10.1038/s41433-020-1084-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-020-1084-9</ArticleId><ArticleId IdType="pmc">PMC7347265</ArticleId><ArticleId IdType="pubmed">32647303</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusef YN, Kazaryan EE, Andzhelova DV, Vorobyova MV. Ophthalmological manifestations of post-COVID-19 syndrome. Russ Ann Ophthalmol. (2021) 137:331&#x2013;9. doi: 10.17116/oftalma2021137052331, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.17116/oftalma2021137052331</ArticleId><ArticleId IdType="pubmed">34669345</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S, Kannan NB, Kumar J, Rajan RP, Kumar K, Baliga G, et al. . Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review. Int Ophthalmol. (2022) 42:323&#x2013;36. doi: 10.1007/s10792-021-01996-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-021-01996-7</ArticleId><ArticleId IdType="pmc">PMC8356207</ArticleId><ArticleId IdType="pubmed">34379290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayachit A, Joshi M, Ayachit G, Joshi S, Shah P. Presumed post-COVID infection retinitis - clinical and tomographic features of retinitis as a post-COVID syndrome. Ocul Immunol Inflamm. (2023) 31:1117&#x2013;21. doi: 10.1080/09273948.2022.2060264, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2022.2060264</ArticleId><ArticleId IdType="pubmed">35404760</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi A, Schiuma M, Parrulli S, Torre A, Zicarelli F, Colombo V, et al. . Retinal vessels modifications in acute and post-COVID-19. Sci Rep. (2021) 11:19373. doi: 10.1038/s41598-021-98873-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98873-1</ArticleId><ArticleId IdType="pmc">PMC8481283</ArticleId><ArticleId IdType="pubmed">34588541</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TTP, Ni S, Khan S, Wei X, Ostmo S, Chiang MF, et al. . Advantages of Widefield optical coherence tomography in the diagnosis of retinopathy of prematurity. Front Pediatr. (2022) 9:1&#x2013;7. doi: 10.3389/fped.2021.797684, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.797684</ArticleId><ArticleId IdType="pmc">PMC8806029</ArticleId><ArticleId IdType="pubmed">35118032</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>